On March 13, 2024, Agile Therapeutics, issued a press release announcing that it has paid-off the remainder of its debt facility with Perceptive Credit Holdings III, LP, thereby completing the repayment schedule contemplated by the Loan Agreement between the Company and Perceptive, which originated in 2020 and ended as of March 11, 2024. As previously disclosed, on February 10, 2020, the Company entered into a Credit Agreement and Guaranty with Perceptive, for a senior secured term loan credit facility of up to $35.0 million (as amended from time to time, the ?Perceptive Credit Agreement?). On February 9, 2024, the Company and Perceptive entered into an eighth amendment to the Perceptive Credit Agreement, which extended the maturity date of the Perceptive Credit Agreement from February 10, 2024 until March 11, 2024.

As previously disclosed, beginning on December 1, 2023, the Company has been making monthly payments of $150,000 on the outstanding loan balance, which payments will now cease with the Company?s repayment of its debt to Perceptive.